Vyant Bio, Inc.

VYNT · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Assets
Cash & Equivalents$10,041$20,608$792$3,880
Short-Term Investments$0$0$0$0
Receivables$323$434$389$696
Inventory$53$475$415$0
Other Curr. Assets$1,092$1,697$191$2,602
Total Curr. Assets$11,509$23,214$1,787$7,178
Property Plant & Equip (Net)$2,648$1,693$2,126$652
Goodwill$0$0$2,977$3,090
Intangibles$0$0$0$2,895
Long-Term Investments$0$0$0$92
Tax Assets$0$0$0$0
Other NC Assets$1,048$12,729-$2,841$997
Total NC Assets$3,696$14,422$2,262$7,726
Other Assets$0$0$0$0
Total Assets$15,205$37,636$4,049$14,904
Liabilities
Payables$655$740$1,300$0
Short-Term Debt$565$331$486$1,277
Tax Payable$0$0$0$0
Deferred Revenue$72$74$92$1,217
Other Curr. Liab.$2,373$4,286$171$4,478
Total Curr. Liab.$3,665$5,431$2,049$6,972
LT Debt$1,631$866$7,466$117
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$49$30,974$430
Total NC Liab.$1,631$915$38,440$547
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$5,296$6,346$40,489$7,519
Equity
Pref Stock$0$0$29,007$0
Common Stock$1$3$223$0
Retained Earnings-$101,503-$78,813-$37,954-$164,424
AOCI-$32-$74-$223-$495
Other Equity$111,443$110,174-$27,716$7,385
Total Equity$9,909$31,290-$36,440$7,385
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$15,205$37,636$4,049$14,904
Net Debt-$7,845-$19,411$7,160-$2,486
Vyant Bio, Inc. (VYNT) Financial Statements & Key Stats | AlphaPilot